How long can you live after a glioma relapses? How to treat a glioma relapse?

The appearance of glioma has a great impact on patients. Most patients delay treatment in the early stage, which leads to life-threatening situations. Therefore, they are very concerned about how long they can live. So, let's find out how long they can live after glioma recurrence!

Survival depends on the severity of the patient's condition, the body's sensitivity to drugs, and a reasonable treatment plan. Each person is different. It is closely related to the patient's condition, constitution, and treatment plan. Active treatment is very critical. Generally speaking, the shortest survival time after glioma recurrence is 1 year. If actively treated, the survival time can be extended.

You cannot be lucky when glioma recurs. There is no definite duration for its survival cycle. I am afraid that even doctors cannot accurately predict the patient's time of death. Therefore, doctors can only decide based on the patient's physical condition and the treatment method they choose. In comparison, the faster the existing cancer cells in the body are cleared, the more likely the patient will win the first stage of treatment time. At the same time, the less traumatic, safer, and more thorough the treatment method is, the longer the patient will survive. Glioma is difficult to cure and often recurs. After the tumor recurs, surgery, radiotherapy, chemotherapy and other treatments may be considered again depending on the patient's functional condition.

After comprehensive treatment, the median survival of patients with low-grade gliomas (WHO grade 1-2) is between 8 and 10 years; for patients with anaplastic gliomas (WHO grade 3), the median survival is between 3 and 4 years, and for patients with glioblastomas (WHO grade 4), the median survival is between 14.6 and 17 months. It is worth noting that for patients with glioblastoma, the newly emerged radiotherapy and temozolomide chemotherapy regimen can enable nearly 10% of patients to survive for more than 5 years; before the emergence of temozolomide, only less than 1% of patients could survive for 5 years using radiotherapy alone.